| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $49.8M | +60.2% |
| Cost of Revenue | $274K | -55.5% |
| R&D Expense | $61.1M | -27.7% |
| SG&A Expense | $37.3M | -73.9% |
| Operating Income | -$48.9M | +75.2% |
| Income Tax | $0 | — |
| Net Income | -$50.3M | +74.9% |
| EPS (Basic) | -$0.14 | +77.8% |
| EPS (Diluted) | -$0.14 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.3M | -48.5% |
| Short-term Investments | $61.9M | -63.9% |
| Accounts Receivable | $2.4M | -31.4% |
| Inventory | $281K | +21.6% |
| Current Assets | $101.9M | -58.6% |
| Total Assets | $185.0M | -38.0% |
| Current Liabilities | $20.9M | -53.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.9M | +62.0% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $113.0M | +834.9% |
| Financing Cash Flow | -$48.5M | -120.3% |
| Free Cash Flow | -$67.9M | +62.3% |
| +77.8% |
| Long-term Debt |
| $49.4M |
| -50.7% |
| Total Liabilities | $77.4M | -49.2% |
| Stockholders' Equity | $107.5M | -26.3% |